Back

Coronary artery disease and the bad dual: homocysteine and lipoprotein (a)

29 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (1) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Francisco Sousa

Hospital Central do Funchal, Funchal (Portugal)

6 More presentations in this session

Presentation thumbnail
Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study
Doctor X. Li (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Small dense low-density lipoprotein cholesterol potentiates the risk of Lp(a) for long-term secondary prevention in patients with stable coronary artery disease
Professor S. Koba (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiac myosin binding protein C in the general population: The Akershus Cardiac Examination 1950 Study
Doctor M. Lyngbakken (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Clonal Hematopoiesis and Cardiovascular Outcomes in the Elderly
Mr D. Ezzat (BE)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol-inflammatory index predicts antiplatelet reactivity and 5-year ischemic risk: a cohort study of 6,555 post-PCI patients
Miss M. Liu (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein (a), coronary artery disease risk, and MACE in individuals without standard modifiable risk factors in the UK Biobank
thumbnail
Congress Presentation
Lipoprotein A and cardiovascular risk in acute myocardial infarction: what have we learned in 5 years?
thumbnail
Congress Presentation
Impact of lipoprotein A on long-term outcomes in acute coronary syndrome: a retrospective cohort analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources